Medicine & Life Sciences
Neoplasms
100%
Endometrioid Carcinoma
72%
Vulva
68%
Ovarian Neoplasms
67%
Radioimmunotherapy
62%
Endometrial Neoplasms
61%
Hysterectomy
60%
Uterine Cervical Neoplasms
59%
Oncogene Proteins
55%
Pandemics
47%
liposomal doxorubicin
46%
Recurrence
37%
Rhenium-188
34%
Carcinoma
33%
Malignant Mixed Tumor
33%
Survival
30%
Surgical Oncology
30%
Endometrial Hyperplasia
28%
Ovary
25%
Neoplasm Metastasis
24%
Adenocarcinoma
23%
Therapeutics
23%
Glutathione Peroxidase
23%
Quality Improvement
21%
Wolffian tumor
21%
Squamous Cell Carcinoma
20%
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
20%
Transcriptome
20%
Antibodies
20%
Lutetium-177
19%
C1P5 monoclonal antibody
19%
Single Nucleotide Polymorphism
18%
Cod Liver Oil
18%
Vaginal Hysterectomy
18%
AIDS-related Kaposi sarcoma
18%
Ascites
18%
Genes
17%
Groin
17%
Human papillomavirus 16
17%
Electrosurgery
16%
Peutz-Jeghers Syndrome
16%
Papanicolaou Test
16%
Gestational Trophoblastic Disease
15%
Monoclonal Antibodies
15%
Clonal Evolution
15%
Neoplasm Antibodies
15%
Molecular Targeted Therapy
15%
Proteasome Inhibitors
15%
Histology
14%
Conservative Treatment
14%
Antioxidants
14%
Pemetrexed
14%
Cytoreduction Surgical Procedures
14%
Progression-Free Survival
13%
Cardiotoxicity
13%
Papillomaviridae
13%
Vagina
13%
Epidural Analgesia
13%
Paclitaxel
13%
Granulosa Cells
13%
Pathologists
13%
Intestinal Obstruction
13%
Drug Therapy
13%
Laparoscopy
12%
Ovarian Epithelial Carcinoma
12%
Growth
12%
Amenorrhea
12%
Bevacizumab
12%
Length of Stay
12%
Oxidation-Reduction
12%
Cisplatin
12%
Inhibins
11%
Lymph Nodes
11%
Medicine
11%
Transforming Growth Factors
11%
Genome-Wide Association Study
11%
Endometrium
11%
Microarray Analysis
11%
Head and Neck Neoplasms
11%
Radiotherapy
11%
Referral and Consultation
11%
Multiple Myeloma
11%
Treatment Failure
10%
Crohn Disease
10%
Sarcoma
10%
Disease-Free Survival
10%
Fertility
10%
Adenoma
10%
Teaching Hospitals
10%
Fingers
10%
University Hospitals
9%
Cell Biology
9%
Postoperative Complications
9%
Radiation
9%
Peritoneum
9%
Oxidants
9%
Pregnant Women
9%
Disease Progression
8%